Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Investments (2022 - 2025)

Historic Long-Term Investments for Cellebrite DI (CLBT) over the last 4 years, with Q4 2025 value amounting to $151.5 million.

  • Cellebrite DI's Long-Term Investments rose 4883.81% to $151.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $151.5 million, marking a year-over-year increase of 4883.81%. This contributed to the annual value of $151.5 million for FY2025, which is 4883.81% up from last year.
  • Per Cellebrite DI's latest filing, its Long-Term Investments stood at $151.5 million for Q4 2025, which was up 4883.81% from $117.1 million recorded in Q3 2025.
  • Cellebrite DI's 5-year Long-Term Investments high stood at $151.5 million for Q4 2025, and its period low was $22.1 million during Q4 2022.
  • Over the past 4 years, Cellebrite DI's median Long-Term Investments value was $64.2 million (recorded in 2023), while the average stood at $74.7 million.
  • In the last 5 years, Cellebrite DI's Long-Term Investments surged by 669.45% in 2023 and then skyrocketed by 25281.19% in 2024.
  • Cellebrite DI's Long-Term Investments (Quarter) stood at $22.1 million in 2022, then surged by 30.44% to $28.9 million in 2023, then surged by 252.81% to $101.8 million in 2024, then surged by 48.84% to $151.5 million in 2025.
  • Its last three reported values are $151.5 million in Q4 2025, $117.1 million for Q3 2025, and $146.9 million during Q2 2025.